NasdaqCM - Nasdaq Real Time Price
USD
Intensity Therapeutics, Inc. (INTS)
3.0900
-0.0600
(-1.90%)
At close: November 10 at 4:00:01 PM EST
Loading chart for INTS
Chart does not reflect overnight price.
- Previous Close
3.1500 - Open
2.9717 - Bid 2.6700 x 200
- Ask 4.4600 x 200
- Day's Range
2.9717 - 3.2600 - 52 Week Range
2.8000 - 15.0000 - Volume
8,653 - Avg. Volume
23,926 - Market Cap (intraday)
10.201M - Beta (5Y Monthly) 3.04
- PE Ratio (TTM)
-- - EPS (TTM)
-3.7900 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
18.67 - Moby Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/10/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
INTS
69.85%
S&P 500 (^GSPC)
9.87%
1-Year Return
INTS
70.64%
S&P 500 (^GSPC)
10.08%
3-Year Return
INTS
95.46%
S&P 500 (^GSPC)
70.34%
5-Year Return
INTS
97.92%
S&P 500 (^GSPC)
61.85%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-89.91%
-
Return on Equity (ttm)
-195.88%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-11.16M
-
Diluted EPS (ttm)
-3.7900
Balance Sheet and Cash Flow
-
Total Cash (mrq)
9.53M
-
Total Debt/Equity (mrq)
1.03%
-
Levered Free Cash Flow (ttm)
-6.28M
